The Development of Molecular Biology of Osteoporosis
Open accessThe DOI matches its Crossref record; 164 of the 168 references it cites were found in a registry or an index.
Abstract
Osteoporosis is one of the major bone disorders that affects both women and men, and causes bone deterioration and bone strength. Bone remodeling maintains bone mass and mineral homeostasis through the balanced action of osteoblasts and osteoclasts, which are responsible for bone formation and bone resorption, respectively. The imbalance in bone remodeling is known to be the main cause of osteoporosis. The imbalance can be the result of the action of various molecules produced by one bone cell that acts on other bone cells and influence cell activity. The understanding of the effect of these molecules on bone can help identify new targets and therapeutics to prevent and treat bone disorders. In this article, we have focused on molecules that are produced by osteoblasts, osteocytes, and osteoclasts and their mechanism of action on these cells. We have also summarized the different pharmacological osteoporosis treatments that target different molecular aspects of these bone cells to minimize osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 The mechanism of action of osteoporosis therapeutics. The antiresorptive drugs such as bisphosphonate (BP), estrogen, anti-RANKLs (denosumab) and calcitonin; anabolic drugs such as PTH and anti-sclerostins (romosozumab) affecting different bone cells. + mean positive effect; − mean negative effect [10].](https://figures.cochat.ai/paper-figures/4698d96068934158895238e5275274e6/the-development-of-molecular-biology-of-osteoporosis-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Thus, it is thought that imbalances in these molecular and cellular processes alter bone homeostasis, driving the pathophysiology of osteoporosis [5,6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Self-citationNakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608 · cited 1×
“In these mice, mesenchymal cells could not deposit bone matrix, whereas cells in the periosteum failed to differentiate into osteoblasts [53].”
BackgroundDenosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Saag, K. G., Petersen, J., Brandi, M. L., Karaplis, A. C., Lorentzon, M., Thomas, T., Maddox, J., Fan, M., Meisner, P. D., & Grauer, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708322 · Cited by 1,544
Cellular and molecular mechanisms of bone remodeling
Raggatt, L. J., & Partridge, N. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.041087 · Cited by 1,402 · cited 1×
“Non-collagenous proteins, such as proteoglycans, alkaline phosphatase, small integrin-binding ligand (SIBLING) proteins, Gla-containing proteins (matrix Gla protein and osteocalcin), and lipids then form the remaining organic material and hydroxylapatite is deposited into new bone, replacing the resorbed bone [19].”
BackgroundEstrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts
Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.025 · Cited by 1,013
Khosla, S., Oursler, M. J., & Monroe, D. G. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.03.008 · Cited by 943
Cited by
Items 101–113 of 113
Osteoporozun diaqnostikasında yeni yanaşmalar
Amirova, A. F., & Mammadrakhimova, A. I. (2024) · Actual Questions of Modern Gynecology and Perinatology · doi:10.28942/mgpam.v11i3.142
A Discussion on Primary Osteoporosis Comorbidities Based on Liver, Spleen, and Kidney Functions
何, 寅. (2024) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2024.34358
Chen, Y., Ying, R., Ai, L., Dai, F., Zhang, Q., Wang, P., & Chen, F. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112751 · Cited by 2
Xiao, Y., Wang, R., Long, Y., Dai, W., & Nie, H. (2025) · ChemistrySelect · doi:10.1002/slct.202501324
Jiang, T., Xiao, H., Li, B., He, H., Wang, H., & Chen, L. (2023) · Figshare · doi:10.6084/m9.figshare.22688844
Osteoporosis - prevention, diagnosis and treatment
Studýnková, J. T. (2025) · Vnitřní lékařství · doi:10.36290/vnl.2025.056
Chen, S.-H., Jiang, Y., Xie, G.-Q., Fang, Z.-H., Zhang, B.-Y., Jiang, C., & Zhu, J. (2026) · Current Medical Science · doi:10.1007/s11596-026-00182-z
Regulating Glucose Metabolism Enzymes for Osteoporosis Therapy: Current and Future Approaches
Zhang, Z., Tian, S., Li, Q., Du, X., Wang, L., Li, N., Zhao, F., & Liu, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104536 · Cited by 1
Targeting ferroptosis in osteoporosis: mechanisms and natural products therapies
Cao, Z., Zhang, C., Yang, X., Shen, Y., & Bai, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1726949
Feature‐Driven Deep Learning for Osteoporosis Detection: Leveraging Explainable AI
Hosain, A. K. M. S., & Zereen, A. N. (2026) · Applied Computational Intelligence and Soft Computing · doi:10.1155/acis/8214937
THE IMPACT OF PHYSICAL ACTIVITY ON THE DEVELOPMENT OF OSTEOPOROSIS: A SYSTEMATIC REVIEW
Grzesikowski, P. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6615
Non-coding RNAs regulating autophagy in Osteoporosis: mechanistic insights and therapeutic potential
王新平, Cai, Y., Liu, R., Xiao, Y., Liu, W., & Zhao, K. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12930-4
Metadata
- Authors
- Gao, Y., Patil, S., & Jia, J.
- Affiliations
- Tangshan Normal University (CN)
- Northwestern Polytechnical University (CN)
- Corresponding author
- Gao, Yongguang
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-07-30
- Volume
- 22
- Issue
- 15
- Pages
- 8182
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8347149
- OpenAlex
- W3191096784
- Cited by
- 116
- References
- 168
- Citations by year
- 2026: 9 · 2025: 27 · 2024: 33 · 2023: 22 · 2022: 18 · 2021: 6
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Science Foundation of Hebei Province (2021105001)
- Key project for scientific research in colleges and universities of Hebei province (ZD2021408)
- Scientific Research Foundation of Tangshan normal university (2021A03)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- osteoporosis, bone remodeling, osteoblasts, osteoclasts, osteocytes, bone resorption, bone formation, bone mineral homeostasis, paracrine signaling, bone disease
- MeSH terms
- Calcium-Regulating Hormones and Agents, Animals, Humans, Osteoclasts, Osteoporosis, Bone Remodeling, Bone Density Conservation Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.